120 related articles for article (PubMed ID: 9012860)
1. Synthesis and characterization of composite nucleic acids containing 2', 5'-oligoriboadenylate linked to antisense DNA.
Xiao W; Player MR; Li G; Zhang W; Lesiak K; Torrence PF
Antisense Nucleic Acid Drug Dev; 1996; 6(4):247-58. PubMed ID: 9012860
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of chimeric 2-5A-DNA oligonucleotides.
Player MR; Torrence PF
Curr Protoc Nucleic Acid Chem; 2001 May; Chapter 4():Unit 4.4. PubMed ID: 18428851
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Bioorg Med Chem Lett; 2003 Nov; 13(22):3959-61. PubMed ID: 14592484
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of antisense oligonucleotides carrying modified 2-5A molecules at their 5'-termini and their properties.
Ueno Y; Kato Y; Okatani S; Ishida N; Nakanishi M; Kitade Y
Bioconjug Chem; 2003; 14(3):690-6. PubMed ID: 12757397
[TBL] [Abstract][Full Text] [Related]
5. 2',5'-Oligoadenylate:antisense chimeras--synthesis and properties.
Lesiak K; Khamnei S; Torrence PF
Bioconjug Chem; 1993; 4(6):467-72. PubMed ID: 8305516
[TBL] [Abstract][Full Text] [Related]
6. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
7. High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2'-5'-oligoadenylates.
Morin B; Rabah N; Boretto-Soler J; Tolou H; Alvarez K; Canard B
Antiviral Res; 2010 Sep; 87(3):345-52. PubMed ID: 20547186
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and properties of second-generation 2-5A-antisense chimeras with enhanced resistance to exonucleases.
Li G; Xiao W; Torrence PF
J Med Chem; 1997 Aug; 40(18):2959-66. PubMed ID: 9288179
[TBL] [Abstract][Full Text] [Related]
9. Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense.
Xiao W; Li G; Player MR; Maitra RK; Waller CF; Silverman RH; Torrence PF
J Med Chem; 1998 Apr; 41(9):1531-9. PubMed ID: 9554886
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Nucleic Acids Res Suppl; 2003; (3):63-4. PubMed ID: 14510381
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of the antisense oligonucleotides carrying the modified 2-5A molecules at their 5'-termini and their properties.
Ueno Y; Kato Y; Okatani S; Kitade Y
Nucleic Acids Res Suppl; 2002; (2):45-6. PubMed ID: 12903097
[TBL] [Abstract][Full Text] [Related]
12. Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.
Player MR; Maitra RK; Silverman RH; Torrence PF
Antivir Chem Chemother; 1998 May; 9(3):225-31. PubMed ID: 9875401
[TBL] [Abstract][Full Text] [Related]
13. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras.
Maran A; Maitra RK; Kumar A; Dong B; Xiao W; Li G; Williams BR; Torrence PF; Silverman RH
Science; 1994 Aug; 265(5173):789-92. PubMed ID: 7914032
[TBL] [Abstract][Full Text] [Related]
14. Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.
Maitra RK; Li G; Xiao W; Dong B; Torrence PF; Silverman RH
J Biol Chem; 1995 Jun; 270(25):15071-5. PubMed ID: 7797490
[TBL] [Abstract][Full Text] [Related]
15. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic synthesis of (2'-5')-linked oligoadenylates on a preparative scale.
Samanta H; Lengyel P
Methods Enzymol; 1986; 119():516-21. PubMed ID: 3762408
[No Abstract] [Full Text] [Related]
17. Methods for the characterization of phosphatase-stabilized 2-5A-antisense chimeras.
Player MR; Xiao W; Cramer H; Torrence PF
Bioconjug Chem; 1998; 9(1):137-42. PubMed ID: 9460557
[TBL] [Abstract][Full Text] [Related]
18. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides.
Cramer H; Player MR; Torrence PF
Bioorg Med Chem Lett; 1999 Apr; 9(7):1049-54. PubMed ID: 10230638
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
Ueno Y; Ishihara S; Ito Y; Kitade Y
Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft models.
Paranjape JM; Xu D; Kushner DM; Okicki J; Lindner DJ; Cramer H; Silverman RH; Leaman DW
Oligonucleotides; 2006; 16(3):225-38. PubMed ID: 16978086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
